Acute coronary syndrome secondary to methylphenidate overdose

Hong Kong Journal of Emergency Medicine

Volumn 17, Issue 1, 2010, Pages 66-70

  Wong, O F ^a   Tsui, K L ^a   Fung, H T ^a  

^a NONE

Author keywords

Amphetamine; Cocaine; Myocardial ischemia; Substance related disorders

Indexed keywords

ACETYLSALICYLIC ACID; BROMPHENIRAMINE; ISOSORBIDE DINITRATE; METHYLPHENIDATE; PARACETAMOL; PERINDOPRIL; TROPONIN;

ACUTE CORONARY SYNDROME; ADJUSTMENT DISORDER; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; OXYGEN THERAPY; SINUS TACHYCARDIA; ST SEGMENT DEPRESSION; STRESS; SUICIDE ATTEMPT; T WAVE INVERSION; THORAX PAIN;

EID: 75749150141     PISSN: 10249079     EISSN: None     Source Type: Journal    
DOI: 10.1177/102490791001700112     Document Type: Article

References (27)

1. Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clin Proc 2000;75(7): 711-21.
2. Rappley MD. Safety issues in the use of methylphenidate. An American perspective. Drug Saf 1997;17(3):143-8.
3. Stowe CD, Gardner SF, Gist CC, Schulz EG, Wells TG. 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy. Ann Pharmacother 2002;36(7-8):1142-9.
4. Findling RL, Short EJ, Manos MJ. Short-term cardiovascular effects of methylphenidate and Adderall. J Am Acad Child Adolesc Psychiatry 2001;40(5): 525-9.
5. Godfrey J. Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. J Psychopharmacol 2009;23(2):194-205.
6. Wax PM. Analeptic use in clinical toxicology: a historical appraisal. J Toxicol Clin Toxicol. 1997:35(2): 203-9.
7. US Food & Drug Administration. Approved uses of methylphenidate. [cited 2009 Jul 20]. Available from : http://www.accessdata.fda.gov/scripts/ cder/drugsatfda/ index.cfm.
8. Seeman P, Madras BK. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 1998;3(5):386-96.
9. Massello W 3rd, Carpenter DA. A fatality due to the intranasal abuse of methylphenidate (Ritalin). J Forensic Sci 1999;44(1):220-1.
10. Markowitz JS, Logan BK, Diamond F, Patrick KS. Detection of the novel metabolite ethylphenidate after methylphenidate overdose with alcohol coingestion. J Clin Psychopharmcol 1999;19(4):362-6.
11. Bailey DN. Comprehensive review of cocaethylene and cocaine concentrations in patients. Am J Clin Pathol 1996;106(6):701-4.
12. US Drug Enforcement Administration. Drug information: methylphenidate. [cited 2009 Mar 14]. Available from: http://www.usdoj.gov/dea/concern/m. html#5.
13. National Institute on Drug Abuse. InfoFacts: methylphenidate (Ritalin), [cited 2009 Mar 14]. Available from: http://www.nida.nih.gov/pdf/infofacts/ Ritalin06.pdf.
14. Klein-Schwartz W, McGrath J. Poison centers' experience with methylphenidate abuse in pre-teens and adolescents. J Am Acad Child Adolesc Psychiatry 2003; 42(3):288-94.
15. Klein-Schwartz W. Abuse and toxicity of methylphenidate. Curr Opin Pediatr 2002;14(2):219-23.
16. Levine B, Caplan YH, Kauffman G. Fatality resulting from methylphenidate overdose. J Anal Toxicol 1986; 10(5):209-10.
17. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995;52(6):456-63.
18. Department of Justice, the Government of the Hong Kong Special Administrative Region. The Laws of Hong Kong. Chapter 134: Dangerous Drugs Ordinance, [cited 2009 May 1]. Available from: http://www. legislation.gov.hk/ eng/home.htm.
19. Schiffer WK, Volkow ND, Fowler JS, Alexoff DL, Logan J, Dewey SL. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 2006;59(4):243-51.
20. Joyce PR, Nicholls MG, Donald RA. Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjects. Life Sci 1984;34(18):1707-11.
21. Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, et al. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl)2003;166(3):264-70.
22. Pearl J. Angina from the proprietary use of methylphenidate. Vet Hum Toxicol 1992;34(4):334.
23. George AK, Kunwar AR, Awasthi A. Acute myocardial infarction in a young male on methylphenidate, bupropion and erythromycin. J Child Adolesc Psychopharmacol 2005;15(4):693-5.
24. Thompson J, Thompson JR. Acute myocardial infarction related to methylphenidate for adult attention deficit disorder. J Emerg Med 2007 Nov 14 [Epub ahead of print].
25. Lange RA, Hillis, LD. Cardiovascular complications of cocaine use. N Engl J Med 2001;345(5):351-8. Erratum in: N Engl J Med 2001;345(19):1432.
26. Chan GM, Sharma R, Price D, Hoffman RS, Nelson LS. Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS). J Med Toxicol 2006;2 (3):108-11.
27. Honderick T, Williams D, Seaberg D, Wears R. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndrome. Am J Emerg Med 2003;21(1): 39-42.